PUMA mediates the combinational therapy of 5-FU and NVP-BEZ235 in colon cancer

Colon cancer is the third most common cancer in humans which has a high mortality rate, and 5-Fluorouracil (5-FU) is one of the most widely used drugs in colon cancer therapy. However, acquired chemoresistance is becoming the major challenges for patients, and the molecular mechanism underlying the...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Huanan, Zhang, Lingling, Yang, Xu, Jin, Yipeng, Pei, Shimin, Zhang, Di, Zhang, Hong, Zhou, Bin, Zhang, Yingjie, Lin, Degui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546474/
https://www.ncbi.nlm.nih.gov/pubmed/25965911

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546474/
https://www.ncbi.nlm.nih.gov/pubmed/25965911

Ejemplares similares